Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 1768
TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339792(US10202340, Example 11)
Affinity DataIC50: 0.840nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339793(US10202340, Example 12)
Affinity DataIC50: 0.870nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339792(US10202340, Example 11)
Affinity DataIC50: 1nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339793(US10202340, Example 12)
Affinity DataIC50: 2.5nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339782(US10202340, Example 1)
Affinity DataIC50: 3nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339783(US10202340, Example 2)
Affinity DataIC50: 3nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339788(US10202340, Example 7)
Affinity DataIC50: 4nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339784(US10202340, Example 3)
Affinity DataIC50: 5nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339785(US10202340, Example 4)
Affinity DataIC50: 5nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339782(US10202340, Example 1)
Affinity DataIC50: 9.40nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339790(US10202340, Example 9)
Affinity DataIC50: 10nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339788(US10202340, Example 7)
Affinity DataIC50: 11nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339787(US10202340, Example 6)
Affinity DataIC50: 11nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339794(US10202340, Example 13)
Affinity DataIC50: 11nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339781(US10202340, Example control)
Affinity DataIC50: 15nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339783(US10202340, Example 2)
Affinity DataIC50: 15nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339790(US10202340, Example 9)
Affinity DataIC50: 17nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339796(US10202340, Example 16)
Affinity DataIC50: 23nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339797(US10202340, Example 17)
Affinity DataIC50: 24nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339781(US10202340, Example control)
Affinity DataIC50: 24nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339784(US10202340, Example 3)
Affinity DataIC50: 27nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339781(US10202340, Example control)
Affinity DataIC50: 27nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339782(US10202340, Example 1)
Affinity DataIC50: 27nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339789(US10202340, Example 8)
Affinity DataIC50: 35nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339791(US10202340, Example 10)
Affinity DataIC50: 38nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339797(US10202340, Example 17)
Affinity DataIC50: 41nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339785(US10202340, Example 4)
Affinity DataIC50: 44nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339787(US10202340, Example 6)
Affinity DataIC50: 45nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339794(US10202340, Example 13)
Affinity DataIC50: 45nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339792(US10202340, Example 11)
Affinity DataIC50: 46nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339796(US10202340, Example 16)
Affinity DataIC50: 47nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339783(US10202340, Example 2)
Affinity DataIC50: 48nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339795(US10202340, Example 14)
Affinity DataIC50: 50nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339784(US10202340, Example 3)
Affinity DataIC50: 54nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339789(US10202340, Example 8)
Affinity DataIC50: 55nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339785(US10202340, Example 4)
Affinity DataIC50: 56nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339793(US10202340, Example 12)
Affinity DataIC50: 56nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339786(US10202340, Example 5)
Affinity DataIC50: 73nMAssay Description:Inhibition of GlcCer production in whole wild-type MDCKII cells.More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339790(US10202340, Example 9)
Affinity DataIC50: 123nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339791(US10202340, Example 10)
Affinity DataIC50: 152nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339788(US10202340, Example 7)
Affinity DataIC50: 232nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339787(US10202340, Example 6)
Affinity DataIC50: 269nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339794(US10202340, Example 13)
Affinity DataIC50: 270nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339791(US10202340, Example 10)
Affinity DataIC50: 299nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339786(US10202340, Example 5)
Affinity DataIC50: 300nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339796(US10202340, Example 16)
Affinity DataIC50: 300nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339797(US10202340, Example 17)
Affinity DataIC50: 300nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339789(US10202340, Example 8)
Affinity DataIC50: 300nMAssay Description:Inhibition of GlcCer synthesis in broken wild-type MDCK cell preparationsMore data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCeramide glucosyltransferase(Human)
The Regents of The University of Michigan

US Patent
LigandPNGBDBM339786(US10202340, Example 5)
Affinity DataIC50: 2.61E+3nMAssay Description:)Inhibition of GlcCer production in MDCKII cells stably expressing human MDR1 (obtained from The Netherlands Cancer Institute).More data for this Ligand-Target Pair
In DepthDetails
US Patent